Vitamin d in pediatric inpatients with respiratory illnesses

Sabah Iqbal1, Edward V Mosenkis, Pankaj Jain

  • 1Division of Emergency Medicine, and.

Hospital Pediatrics
|January 18, 2014
PubMed

Insights

Vitamin D deficiency was common in children hospitalized with respiratory illnesses, but it did not increase their risk or severity. This study found no significant link between low vitamin D levels and respiratory illness outcomes in pediatric patients.

Area of Science:

  • Pediatric Medicine
  • Nutritional Science
  • Infectious Diseases

Background:

  • Low serum 25-hydroxyvitamin D (25[OH]D) is linked to increased respiratory viral infection susceptibility and severity.
  • Vitamin D insufficiency may be a modifiable risk factor for severe viral respiratory illnesses.

Purpose of the Study:

  • To investigate if children hospitalized for respiratory illnesses have lower serum 25(OH)D levels than controls.
  • To determine if 25(OH)D levels correlate with illness severity in pediatric respiratory cases.

Main Methods:

  • A case-control study compared children (6 months–12 years) hospitalized for respiratory illnesses (cases) with those hospitalized for nonrespiratory illnesses (controls).
  • Illness severity was assessed using hospital length of stay, ICU admission, oxygen saturation, and pediatric risk of admission score.
  • Serum 25(OH)D levels were analyzed using logistic and multivariable linear regression, controlling for demographic and clinical factors.

Main Results:

  • The study cohort (N=121) comprised mostly African American children.
  • A high prevalence of vitamin D insufficiency (64.8%) and deficiency (31.1%) was observed in both cases and controls.
  • Mean serum 25(OH)D levels were similar between cases and controls (26.8 ± 11.5 vs 26.1 ± 10.6 ng/mL; P = .73).

Conclusions:

  • Hypovitaminosis D was prevalent in hospitalized children, affecting both those with and without respiratory illnesses.
  • No significant association was found between serum 25(OH)D levels and the presence or severity of respiratory illnesses in this pediatric cohort.
Abstract

Related Concept Videos

Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
768
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
2.1K